Skip to content

CELU

Celularity Inc

NASDAQ · Healthcare · Biotechnology · US

$0.85
−9.66%
Ask drillr

Margins

Gross margin
19.2%
EBITDA margin
-193.9%
EBIT margin
-264.3%
Net margin
-245.7%
FCF margin
-47.8%
129.1%
Return on equity
-47.7%
Return on assets
—
Return on invested capital
0.19x
Asset turnover
-$8.9M
Cash from operations
$0.02
Cash per share

Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026